ACEN Renewable Energy Solutions, the retail electricity arm of Ayala Group's ACEN Corp, has successfully inked a deal with Zuellig Pharma, a prominent healthcare services provider in Asia. The agreement marks a significant stride towards sustainability as ACEN RES commits to providing Zuellig Pharma's two distribution centers in Laguna province, Philippines, with 100% renewable power.
The collaboration, facilitated by the Department of Energy's Retail Competition and Open Access program, enables end-users with high power consumption, like Zuellig Pharma, to choose their electricity suppliers. ACEN RES will draw upon its wind and solar parks to fulfill the contracted electricity volumes, contributing to a substantial reduction in carbon emissions for Zuellig Pharma.
Under this arrangement, the Santa Rosa and Canlubang facilities are expected to witness a noteworthy annual decrease of 10,600 tonnes in their carbon footprint. Jannette Jakosalem, Market Managing Director of Zuellig Pharma Philippines, emphasized the significance of this transition, stating, “The switch to renewable energy for two key distribution facilities in the Philippines is an important milestone for us, as we work towards reducing our impact on the environment and our carbon footprint across our operations and supply chains.”
ACEN Corp currently boasts approximately 4.5 GW of attributable capacity across various countries, including the Philippines, Australia, Vietnam, Indonesia, and India. With an ambitious target of reaching 20 GW by the end of 2030, of which 8 GW will be allocated to its home country, ACEN Corp is positioning itself as a key player in the renewable energy landscape. This initiative aligns with the global push towards sustainable practices and underlines the growing importance of corporations actively participating in environmental stewardship.
